(Q33407192)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Matthieu Resche-Rigon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Patrice Cacoub

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

V Thibault

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Longuet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S Pol

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

F Blanc

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

G Pialoux

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A Karras

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

D Bazin-Karra

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

C Cazorla

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

D Vittecoq

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

L Musset

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

O Decaux

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J M Ziza

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

O Lambotte

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

20 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

Annals of the Rheumatic Diseases

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

831-837

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis

29 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995244

Response-guided telaprevir combination treatment for hepatitis C virus infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995244

Telaprevir for retreatment of HCV infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995244

Telaprevir for previously untreated chronic hepatitis C virus infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995244

Boceprevir for previously treated chronic HCV genotype 1 infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995244

Boceprevir for untreated chronic HCV genotype 1 infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995244

Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995244

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995244

Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995244

Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995244

Biologic and clinical significance of cryoglobulins. A report of 86 cases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995244

Characterization of cryoglobulins by immunoblotting

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995244

A role for hepatitis C virus infection in type II cryoglobulinemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995244

Prediction of creatinine clearance from serum creatinine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995244

Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia

21 June 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202770

Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202770

Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202770

Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202770

Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202770

Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202770

Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202770

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202770

Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23606708

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23606708

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ANNRHEUMDIS-2012-202770

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

23606708

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23606708%20AND%20SRC:MED&resulttype=core&format=json